Barbara Ellers‐Lenz

1.4k citations
28 papers · 964 indexed · 1 hit paper · h-index 13
Topics
Lung Cancer Treatments and Mutations (12 papers)Colorectal Cancer Treatments and Studies (8 papers)Gastric Cancer Management and Outcomes (7 papers)

In The Last Decade

Barbara Ellers‐Lenz

27 papers receiving 943 citations

Hit Papers

Avelumab versus docetaxel in patients with platinum-treat...20182026202020232018100200300

Peers

Barbara Ellers‐Lenz
Comparison fields: 5 of 77
  • Oncology 599
  • Pulmonary and Respiratory Medicine 337
  • Molecular Biology 202
  • Electrical and Electronic Engineering 120
  • Immunology 113
Replace A. Nagano with:
A. Nagano United Kingdom
Christina M. Reinisch Austria
Deborah Ritter United States
Elena Magrini Italy
Raquel Planas Spain
Christian Lang Germany
Harold Koendgen Switzerland
Weixiang Zhong China
Kristyn Gumpper United States
Rebecca S. Cook United States
Barbara Ellers‐Lenz relative to A. Nagano United Kingdom A. Nagano's profile →
Citations per field
00.5×
A. Nagano · 1×
Citations per year

Countries citing papers authored by Barbara Ellers‐Lenz

Since Specialization
Citations

This map shows the geographic impact of Barbara Ellers‐Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ellers‐Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ellers‐Lenz more than expected).

Fields of papers citing papers by Barbara Ellers‐Lenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ellers‐Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ellers‐Lenz. The network helps show where Barbara Ellers‐Lenz may publish in the future.

Co-authorship network of co-authors of Barbara Ellers‐Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ellers‐Lenz. A scholar is included among the top collaborators of Barbara Ellers‐Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ellers‐Lenz. Barbara Ellers‐Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 27
3 0
4 80
5 20
6 1
7 1
8 2
9 134
10 10
11
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 studybreakdown →
336
12 1
13 6
14 3
15 39
16 2
17 11
18 22
19 21
20 14

About Barbara Ellers‐Lenz

Barbara Ellers‐Lenz is a scholar working on Immunology and Allergy, Oncology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 964 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Oncology (599 citations), Neurology (90 citations) and Pulmonary and Respiratory Medicine (337 citations). Barbara Ellers‐Lenz has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Marcis Bajars, Filippo de Marinis, Hidenobu Ishii, Andreas Polychronis, Maciej Krzakowski, Jong Seok Lee, Keunchil Park, David R. Spigel, Fabrice Barlési and Mustafa Özgüroğlu. Their work appears in journals such as Journal of Clinical Oncology, Neurology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026